Her2-BATS
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Her2-BATS, covering 2026-02-27 to 2026-02-27. Get the full timeline:
Most recent: Clinical Trial Update: Her2-BATS and Pembrolizumab in Metastatic Breast Cancer [Phase 1, Phase 2]